Redox and Microglia in the Pathophysiology of Schizophrenia

Overview of attention for article published in Yakugaku Zasshi = Journal of Pharmaceutical Society of Japan, May 2015

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 2 X users

Citations

dimensions_citation: 5 Dimensions

Readers on

mendeley: 17 Mendeley

Summary X Dimensions citations

So far, Dimensions has found 5 publications that cite this research output.

5

The most recent citing publications are shown below. View all 5 publications that cite this research output on Dimensions.

Is It Time for a Paradigm Shift in the Treatment of Schizophrenia? The Use of Inflammation-Reducing and Neuroprotective Drugs—A Review

Article in Brain Sciences (June 2023)

Different phenotypes of microglia in animal models of Alzheimer disease

Article in Immunity & Ageing (October 2022)

Pentadecapeptide BPC 157 counteracts L-NAME-induced catalepsy. BPC 157, L-NAME, L-arginine, NO-relation, in the suited rat acute and chronic models resembling ‘positive-like’ symptoms of schizophrenia

Article in Behavioural Brain Research (September 2020)

This page shows the most recent citations of this research output.

Click here to find out how to access more activity.